Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Taking the journey together: Shared decision-making in psoriatic disease Rob Volansky
• Reflections on ACR Convergence 2020: What we learned Leonard H. Calabrese, DO
• Where rheumatology care stands under Trump, Biden Jason Laday
• Corticosteroids plus tocilizumab superior to standard of care in COVID-19 cytokine storm Jason Laday
• Depression linked to higher risk for seronegative rheumatoid arthritis Jason Laday
• Placebo responses in RA trials extend beyond psychological effects Jason Laday
• Predictive criteria identifies patients at risk for cytokine storm in COVID-19 Jason Laday
• Upadacitinib bests abatacept for efficacy in RA, with greater adverse event risk Jason Laday
• Weight fluctuation increases risk for cardiovascular events in patients with RA Jason Laday
• Corticosteroid injections do not worsen knee OA progression, expedite knee replacement Robert Stott
• Office visits for arthritis, visits with opioids prescribed on the rise Jason Laday
• Risk for stroke three times higher among Black patients with lupus Stacey L. Adams
• Simpler language, slower speech may improve lupus medication adherence Stacey L. Adams
• US patients with RA substantially changed medication in response to COVID-19 Jason Laday
• NOBILITY: Gazyva sustains safety, efficacy against lupus nephritis over 2 years Robert Stott
• ‘Real alliances’ between immunology, rheumatology provide hope for COVID-19 therapy Rob Volansky
• Fauci: COVID-19 'vaccines, plural' may complete trials by late 2020, early 2021 Rob Volansky
• JIA guidelines push for timely immunization, early biologic use, fewer corticosteroids Rob Volansky
• Osteoporosis 'largely ignored' in older men Rob Volansky
• Avacopan reduces glucocorticoid use, recovers renal function in ANCA-associated vasculitis Jason Laday
• Rheumatic diseases do not increase risk for severe COVID-19 outcomes Jason Laday
• Safety tops concerns in drive to develop, distribute COVID-19 vaccines Rob Volansky
• ACR RA guidelines ‘push the needle away’ from glucocorticoids as primary option Rob Volansky
• More than 50% of patients with COVID-19 positive for antiphospholipid antibodies Jason Laday
• Risk for adverse events from trimethoprim-sulfamethoxazole higher in patients with lupus Stacey L. Adams
• Great Debate tackles when to use JAK inhibitors after methotrexate failure in RA Rob Volansky
• National Infusion Center Association navigates 'shifting coverage, reimbursement landscape' Rob Volansky
• ACR, medical societies lobby for legislation ensuring 'overdue' E/M rate increases Jason Laday
• ACR urges UnitedHealthcare to cancel new copay proposal Jason Laday